GlucoTrack Stock Pattern Recognition Stalled Pattern
| GCTK Stock | USD 1.27 -0.07 -5.22% |
| Symbol |
Recognition |
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was twelve with a total number of output elements of forty-nine. The function did not return any valid pattern recognition events for the selected time horizon. The Stalled pattern represents a weakness and consolidation and GlucoTrack possible reversal in trend.
GlucoTrack Technical Analysis Modules
Most technical analysis of GlucoTrack help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for GlucoTrack from various momentum indicators to cycle indicators. When you analyze GlucoTrack charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Stock Overview, Methodology & Data Sources
GlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Israel and internationally. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel. Glucotrack operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 5 people. Downside history and drawdown behavior provide context for risk expectations in GlucoTrack. Past price movements indicate comparatively limited downside dispersion. GlucoTrack has a market cap of 1.28 M, ROE of -14.91%.
Methodology
Unless otherwise specified, financial data for GlucoTrack is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. GlucoTrack (USA Stocks:GCTK) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: Inputs are aggregated from public filings and market reference sources and public institutions such as U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Food & Drug Administration (FDA). Certain values may not reflect real-time changes. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.
Analyst Sources
GlucoTrack may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.
This content is curated and reviewed by:
Raphi Shpitalnik - Junior Member of Macroaxis Editorial BoardBecome your own money manager
Tracking GlucoTrack inside a portfolio is useful because individual winners can still weaken diversification or distort overall risk targets. A disciplined tracking process turns performance data into better decisions instead of more noise.
Did you try this?
Run Stock Screener Now
Stock ScreenerFind equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |
| All Next | Launch Module |
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Disruptive Technologies Invested few shares | |
 | Investor Favorites Invested over 20 shares | |
 | Macroaxis Index Invested over 60 shares | |
 | Social Domain Invested few shares | |
 | Momentum Invested few shares | |
 | Macroaxis Picks Invested few shares | |
 | Adviser Favorites Invested few shares | |
 | Hedge Favorites Invested over 200 shares | |
 | Blockchain Invested few shares | |
 | Data Storage Invested few shares |
More Resources for GlucoTrack Stock Analysis
A structured review of GlucoTrack often starts with core financial statements and trend context. Key ratios help frame profitability, efficiency, and growth context for GlucoTrack Stock. Highlighted below are reports that provide context for GlucoTrack Stock:GlucoTrack has a market cap of 1.28 M, ROE of -14.91%. Risk vs Return Analysis can help frame allocation decisions. The allocation includes a position in GlucoTrack inside the allocation mix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. Explore our How to Trade GlucoTrack Stock guide to learn how to trade GlucoTrack effectively.Analysis related to GlucoTrack should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Market capitalization and book value offer complementary views of GlucoTrack — the first driven by investor sentiment, the second by accounting standards. GlucoTrack's market capitalization is 1.28 M. A P/B ratio of 0.49 suggests GlucoTrack trades near or below book value. Intrinsic value represents an estimate of underlying worth and can differ from both market price and book value. Valuation methods compare these perspectives to frame context.
Value and price for GlucoTrack are related but not identical, and they can diverge across cycles. For GlucoTrack, key inputs include a P/B ratio of 0.49, and ROE of -14.91%. By contrast, market price reflects the level where buyers and sellers transact.